Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
Liesel M FitzGeraldS ZhaoA LeonardsonM S GeybelsS KolbD W LinJ L WrightRosalind A EelesZ Kote-JaraiK GovindasamiG G GilesM C SoutheyJ SchleutkerT L TammelaCsilla SipekyK L PenneyM J StampferH GronbergF WiklundP StattinJ HugossonD M KaryadiE A OstranderZ FengJ L StanfordPublished in: Prostate cancer and prostatic diseases (2018)
This meta-analysis confirms the association of three genetic variants with risk of PCSM, providing further evidence that genetic background plays a role in PCa-specific survival. While these variants alone are not sufficient as prognostic biomarkers, these results may provide insights into the biological pathways modulating tumour aggressiveness.